Navigation Links
Arpida Provides Further Comments on the Pivotal Phase III Trials
Date:4/11/2008

Extensive Data to be Presented at the Upcoming ECCMID Conference

REINACH, Switzerland, April 11 /PRNewswire-FirstCall/ -- Further to the press release published on 9 April, Arpida Ltd. (SWX: ARPN) today elaborates on some additional elements of the clinical programme with intravenous iclaprim in complicated Skin and Skin Structure Infections (cSSSI). Extensive data on ASSIST-1 has been presented at last year's ICAAC and IDSA meetings. Data on ASSIST-2 will be presented at the upcoming 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which takes place in Barcelona, 19-22 April 2008.

As reported in November 2006 and July 2007, intravenous iclaprim achieved its pre-specified primary endpoint in both of the pivotal Phase III trials: ASSIST-1 and ASSIST-2. Generally, two independent trials are preferred by regulatory authorities to confirm the robustness of the data. ASSIST-1 and ASSIST-2 were similarly designed and importantly used the same comparator (i.e. linezolid) which could allow regulators to pool and further analyse the data. Noteworthy to say, that linezolid has been shown to be superior to vancomycin in cSSSI for patients with MRSA infections (Weigelt et al, AAC, June 2005, page 2260-2266).

The aim of these trials is to provide an unbiased assessment of the treatment effect and takes into account all populations; particularly relevant are the Intent-to-Treat (ITT) and the Per-Protocol (PP) population. It is essential and standard practice in any study to remove any significant imbalances, in order to properly analyse the results. As reported in July 2007, imbalances were noted in the ASSIST-2 trial - in particular due to the use of prohibited antibiotics. The correction for this imbalance in the PP population results in the Modified Clinically Evaluable ("MCE") population and shows that the MCE population is in close agreement with the ITT population. The pre-specified primary endpoint for both tria
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
3. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
4. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
5. Raptor Pharmaceuticals Provides Update of Product Programs
6. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
7. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
8. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
11. Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)...  Bayer Corporation hosted its annual "Take Your Child to ... US headquarters.  This is Bayer,s second "Take Your Child To ... campus, and Thursday,s event welcomed 230 children ready to ... Fortunately, for the kids, this was not just ... is "Science For A Better Life," Bayer made sure that ...
(Date:4/24/2015)... CHAPEL HILL, N.C. , April 24, 2015 ... marketplace, organizations are establishing employee groups around the ... workforce and round-the-clock business hours. While there are ... becoming global, leaders must examine which best practices ... global operational excellence. According to ...
(Date:4/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) has ... 2015-2019" report to their offering. The ... a CAGR of 7.07% over the period 2014-2019 ... two segments: Equipment and Consumables. This report covers the ... Biobanking market for the period 2015-2019. ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... ANGELES, Oct. 13, 2011 IVD Technology ... in vitro diagnostics technologies including research, development, and manufacturing, ... most significant emerging trend in the industry ... (CONTACT:   http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ) The ...
... Oct. 13, 2011 PharmAthene, Inc. (NYSE Amex: ... brief in response to SIGA Technologies, motion for reargument.  On ... Chancery had issued a ruling in its litigation against SIGA ... years from all sales of ST-246 and related products after ...
Cached Medicine Technology:Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 2Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 3PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 2PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 3
(Date:4/25/2015)... New Jersey (PRWEB) April 25, 2015 ... people aged twelve and above needed treatment for an ... according to the Substance Abuse and Mental Health Services ... September 2011). Beyond these alarming numbers are harrowing stories ... by substance abuse . David H. Kerr ...
(Date:4/25/2015)... York, NY (PRWEB) April 25, 2015 By ... technology and data for the enterprise relying on their judgement ... running smoothly. But according to an article published ... can many times actually be doing a disservice to their ... i’s are dotted and t’s are crossed when it comes ...
(Date:4/25/2015)... Illinois (PRWEB) April 25, 2015 ... enrichment and wellness, management and operations, and sales ... Meeting and Exhibition scheduled to be held from ... , LeadingAge Illinois is the largest eldercare association ... providers of services for older adults, including senior ...
(Date:4/25/2015)... Sports controversies continue to revolve around issues of ... the case with the Miami Dolphins and Richie Incognito, or off ... Ray Rice domestic abuse case. In a recent episode of ... the implications of locker room culture on teams. He examines what ... should do to improve the locker room as a work place. ...
(Date:4/24/2015)... CA (PRWEB) April 24, 2015 Bird B ... and residential applications now offers a complete line of bird ... to poultry farms. , New Flu Strains Threaten Pacific, Central ... 2015 USDA post , a number of highly pathogenic ... paths. The disease is often spread when wild birds enter ...
Breaking Medicine News(10 mins):Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:David Steele Discusses Locker Room Culture on SCI TV 2Health News:David Steele Discusses Locker Room Culture on SCI TV 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4
... Insulet Corporation,(the "Company") (Nasdaq: PODD ) announced today ... aggregate principal amount of convertible senior,notes due 2013 (the ... on Rule 144A under the Securities Act of 1933, ... an option to,purchase up to an additional $10 million ...
... regulators and ... the healthcare industry, LANSDALE, ... appeal process is a big issue facing healthcare reform, says,NAIRO ... While 44 states and Washington, D.C. have external,review laws, each ...
... Headway, LLC (Medical Headway),is pleased to announce ... MedicalHeadway.com, dedicated to arming the public with ... of medicine. The company offers,consumers free and ... cutting-edge,professional medical treatment and product information., ...
... sleep time, even within the normal range, is associated ... naps, according to a research abstract that will be ... Meeting of the Associated Professional Sleep Societies (APSS). , ... of California at San Diego, focused on 24 healthy ...
... with Down Syndrome sleep poorly, with more fragmented sleep ... to a research abstract that will be presented on ... the Associated Professional Sleep Societies (APSS). , The study, ... of Michigan, focused on 38 children with Down Syndrome, ...
... are more likely to comply with continuous positive airway ... receive their treatment from a sleep center accredited by ... a research abstract that will be presented on Tuesday ... Associated Professional Sleep Societies (APSS). , The study, authored ...
Cached Medicine News:Health News:Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes 2Health News:Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes 3Health News:NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 2Health News:A New Home for Medical Breakthroughs 2Health News:Decreased total sleep time associated with increased REM sleep during subsequent naps 2Health News:Children with Down Syndrome sleep poorly and have more fragmented sleep 2Health News:Treatment at an AASM accredited sleep center improves long-term CPAP compliance 2Health News:Treatment at an AASM accredited sleep center improves long-term CPAP compliance 3
The Guidant Fineline EZ leads with protective capsule are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
... The Model 6491 unipolar ... designed for temporary atrial and ... and after cardiac surgery. This ... downsized, making it the ideal ...
... Guidant Flextend lead is ... lead with an extendable/retractable ... helix design offers various ... permanent implantation in the ...
Medicine Products: